Vimentin and N‐cadherin are key markers of the epithelial–mesenchymal transition (EMT), a process that enhances cell motility and invasiveness, while MMP2 and MMP9 are matrix metalloproteinases involved in the degradation of the extracellular matrix, facilitating tumour invasion and metastasis. The gene discussed is VIM; the disease is neoplasm.